Aporte a la rutina de la trinchera asistencial donde los conocimientos se funden con las demandas de los pacientes, sus necesidades y las esperanzas de permanecer en la gracia de la SALUD.
miércoles, 29 de abril de 2026
FDA Releases FY25 Sampling Results on Economically Motivated Adulteration in Honey
https://www.fda.gov/food/hfp-constituent-updates/fda-releases-fy25-sampling-results-economically-motivated-adulteration-honey?utm_medium=email&_hsenc=p2ANqtz-8jvSYPL9bouVvar0Tp-3UrqfgtO-WjTzMDMaFb5u-4O8xF3M3n7sgrDqpBrQHlBehTp1ltfwc935DvUC7YI4NoMmwwIw&_hsmi=416156928&utm_source=govdelivery
FDA Sampling Results Reinforce Focus on Economically Motivated Adulteration
FDA has released FY2025 sampling results highlighting its ongoing focus on economically motivated adulteration (EMA), where products are altered or diluted to reduce costs without proper disclosure. While the testing focused on honey, the broader priority is detecting ingredient substitution and fraud across food imports. For importers and exporters, this reinforces the need for strong supplier verification, product testing, and documentation, as adulteration risks can trigger import alerts, refusals, and increased regulatory scrutiny.
No hay comentarios:
Publicar un comentario